Alok Raghav

1.2k total citations
42 papers, 871 citations indexed

About

Alok Raghav is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Alok Raghav has authored 42 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 7 papers in Clinical Biochemistry. Recurrent topics in Alok Raghav's work include Extracellular vesicles in disease (8 papers), Advanced Glycation End Products research (7 papers) and Wound Healing and Treatments (6 papers). Alok Raghav is often cited by papers focused on Extracellular vesicles in disease (8 papers), Advanced Glycation End Products research (7 papers) and Wound Healing and Treatments (6 papers). Alok Raghav collaborates with scholars based in India, South Korea and United States. Alok Raghav's co-authors include Jamal Ahmad, Saba Noor, Brijesh Kumar Mishra, Zeeshan Ahmad Khan, Goo‐Bo Jeong, Rajendra Kumar Labala, Jamal Ahmad, Khursheed Alam, Ashok Kumar and Parvaiz Ahmad Shiekh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Food Chemistry.

In The Last Decade

Alok Raghav

41 papers receiving 858 citations

Peers

Alok Raghav
Alok Raghav
Citations per year, relative to Alok Raghav Alok Raghav (= 1×) peers Ching‐Shuang Wu

Countries citing papers authored by Alok Raghav

Since Specialization
Citations

This map shows the geographic impact of Alok Raghav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Raghav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Raghav more than expected).

Fields of papers citing papers by Alok Raghav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok Raghav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Raghav. The network helps show where Alok Raghav may publish in the future.

Co-authorship network of co-authors of Alok Raghav

This figure shows the co-authorship network connecting the top 25 collaborators of Alok Raghav. A scholar is included among the top collaborators of Alok Raghav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok Raghav. Alok Raghav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Raghav, Alok & Goo‐Bo Jeong. (2024). Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma. Cells. 13(7). 638–638. 2 indexed citations
4.
Upadhayay, Viabhav Kumar, Ajay Veer Singh, Amir Khan, et al.. (2022). FE-SEM/EDX Based Zinc Mobilization Analysis of Burkholderia cepacia and Pantoea rodasii and Their Functional Annotation in Crop Productivity, Soil Quality, and Zinc Biofortification of Paddy. Frontiers in Microbiology. 13. 852192–852192. 19 indexed citations
5.
Raghav, Alok, et al.. (2022). New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review. Frontiers in Endocrinology. 13. 1036220–1036220. 2 indexed citations
6.
Singh, Anamika, Alok Raghav, Parvaiz Ahmad Shiekh, & Ashok Kumar. (2021). Transplantation of engineered exosomes derived from bone marrow mesenchymal stromal cells ameliorate diabetic peripheral neuropathy under electrical stimulation. Bioactive Materials. 6(8). 2231–2249. 77 indexed citations
7.
Raghav, Alok, Syed Ghazanfar Ali, Goo‐Bo Jeong, et al.. (2021). Newer Horizon of Mesenchymal Stem Cell–Based Therapy in the Management of SARS-CoV-2–Associated Mucormycosis: A Safe Hope for Future Medicine. Frontiers in Microbiology. 12. 738983–738983. 2 indexed citations
8.
Raghav, Alok & Goo‐Bo Jeong. (2021). A systematic review on the modifications of extracellular vesicles: a revolutionized tool of nano-biotechnology. Journal of Nanobiotechnology. 19(1). 459–459. 44 indexed citations
9.
Raghav, Alok, Prashant Tripathi, Brijesh Kumar Mishra, et al.. (2021). Mesenchymal Stromal Cell-Derived Tailored Exosomes Treat Bacteria-Associated Diabetes Foot Ulcers: A Customized Approach From Bench to Bed. Frontiers in Microbiology. 12. 712588–712588. 27 indexed citations
10.
Raghav, Alok, Prerna Singh, & Jamal Ahmad. (2019). New insights into bioelectronic medicines: A new approach to tackle diabetic peripheral neuropathy pain in clinics. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(2). 1011–1014. 5 indexed citations
11.
Raghav, Alok, Jamal Ahmad, & Imrana Naseem. (2019). Chronic unpredictable environmental stress impair biochemical and physiological homeostasis: Role in diabetes mellitus. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(2). 1021–1030. 11 indexed citations
12.
Raghav, Alok, Jamal Ahmad, & Khursheed Alam. (2018). Preferential recognition of advanced glycation end products by serum antibodies and low-grade systemic inflammation in diabetes mellitus and its complications. International Journal of Biological Macromolecules. 118(Pt B). 1884–1891. 11 indexed citations
13.
Raghav, Alok & Jamal Ahmad. (2018). Glycated albumin in chronic kidney disease: Pathophysiologic connections. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(3). 463–468. 12 indexed citations
14.
Raghav, Alok, Jamal Ahmad, Saba Noor, Khursheed Alam, & Brijesh Kumar Mishra. (2018). Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(3). 381–385. 8 indexed citations
15.
Noor, Saba, et al.. (2017). Inflammatory markers as risk factors for infection with multidrug-resistant microbes in diabetic foot subjects. The Foot. 32. 44–48. 17 indexed citations
16.
Noor, Saba, et al.. (2017). Prevalence of thyroid disorders in North Indian Type 2 diabetic subjects: A cross sectional study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(3). 301–304. 25 indexed citations
17.
Islam, Sidra, Abdul Rouf Mir, Alok Raghav, et al.. (2017). Neo-Epitopes Generated on Hydroxyl Radical Modified GlycatedIgG Have Role in Immunopathology of Diabetes Type 2. PLoS ONE. 12(1). e0169099–e0169099. 14 indexed citations
18.
Raghav, Alok, Jamal Ahmad, Khursheed Alam, & Asad U. Khan. (2017). New insights into non-enzymatic glycation of human serum albumin biopolymer: A study to unveil its impaired structure and function. International Journal of Biological Macromolecules. 101. 84–99. 23 indexed citations
19.
Raghav, Alok, Jamal Ahmad, & Khursheed Alam. (2015). Impact of glycation on structural and antioxidant function of human serum albumin: Relevance in diabetic complications. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 10(2). 96–101. 13 indexed citations
20.
Raghav, Alok & Jamal Ahmad. (2014). Glycated serum albumin: A potential disease marker and an intermediate index of diabetes control. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 8(4). 245–251. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026